The Impact of Banning Pharmaceutical Representatives in Indian Hospitals

This chapter explores the Indian government's ban on pharmaceutical representatives in government hospitals and its implications for healthcare. It delves into the ethical complexities between doctors and the pharmaceutical industry, addressing concerns about information flow and the tender system for medication supply.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app